Abstract:
Sterilized dialysis solutions containing glycosaminoglycan, for example Heparin, and methods of making and using same are provided. In an embodiment, the present invention provides different peritoneal dialysis solutions containing Heparin that are stable under sterilization conditions. For example, the solutions are designed to provide all-in-one, ready-to-use sterilized solutions for peritoneal dialysis.
Abstract:
The present disclosure provides a sterilized medical system that includes an ultra high pressure sterilized glucose solution in a container. The sterile glucose solution may contain less than about 40 ppm total glucose degradation product. The glucose solution may be a ready-to-use infusion solution disposed in a single chamber container.
Abstract:
A peritoneal dialysis solution buffered with L-histidine to a pH of at least 6.5. An apparatus and method for utilizing the solution is also disclosed.
Abstract:
A method and device for stabilizing and storing bicarbonate solutions is provided. In an embodiment, a device is provided having a container and carbon-dioxide generating substances that include a solid material which upon contact with water generates carbon-dioxide gas. The device may be packaged together with the bicarbonate or in a separate overpouch. The present invention also provides a method for the stabilization of bicarbonate solutions utilizing a means that generates high pressure carbon dioxide.
Abstract:
La presente invención proporciona un sistema médico esterilizado que incluye una solución de glucosa esterilizada a alta presión en un contenedor o recipiente. La solución de glucosa estéril puede contener menos de aproximadamente 40 ppm del producto de degradación de glucosa total. La solución de glucosa puede ser una solución de infusión lista para usarse dispuesta en un contenedor de de cámara individual.
Abstract:
Composición farmacéutica estable que comprende una cantidad terapéuticamente eficaz de eritropoyetina y un estabilizante de péptido seleccionado de entre el grupo consistente en Gly-Gly, Gly-Gly-Gly, Gly-Tyr, Gly-Phe, Gly- His, Gly-Asp, Gly-Ala, Ala-Gly, Ala-Ala, derivados de los mismos y mezclas de los mismos, caracterizada porque la composición está exenta de seroalbúmina.
Abstract:
A container (10) is provided comprising a body defined, at least in part, by a film, the body including at least one side seal, at leas t two chambers (12, 14) separated, at least in part, by a peelable seal, and the film including a sealant layer having a bimodal thermal behavior such that the si de seal is a permanent seal and the peelable seal (16) can, at least in part, b e sep-arated.